Bottom line
RSLCX vs SPDW: the short answer
RSLCX (Smallcap World Fund Inc) and SPDW (State Street(R) SPDR(R) Portfolio Developed World ex-US ETF) are both mutual funds.
But SPDW is far broader, holding 2,458 positions to 862 for RSLCX, so beyond the top names it adds exposure RSLCX doesn't have.
SPDW is cheaper at 0.03% vs 1.3% — a difference of $127 a year per $10,000 invested.
Over five years, SPDW returned +8.9% a year vs +5.0% for RSLCX (reporting dates differ).
Updated Nov 19, 2026
RSLCX vs SPDW side by side
| RSLCX | SPDW | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | American Funds (Capital Group) | SPDR (State Street) |
| Category | Global Stock | International Stock |
| Expense ratio | 1.3% | 0.03% |
| Annual cost per $10k | $130 | $3 |
| 10-yr cost on $10k (prospectus) | $1,568 | $39 |
| Max front load | 0% | None |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +2.1% | +34.5% |
| 5-yr return (annualized) | +5.0% | +8.9% |
| 10-yr return (annualized) | +7.4% | +8.6% |
| Best quarter | +31.9% | +17.0% |
| Worst quarter | −22.5% | −23.4% |
| Net assets (fund) | $94.6B | $40.3B |
| Number of holdings | 862 | 2,458 |
| Portfolio turnover | 41% | 3% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
RSLCX and SPDW share none of their top holdings.
RSLCX top 10
- Capital Group Central Cash Fund — 2.65%
- Kokusai Electric Corp — 1.37%
- Mks Inc — 1.15%
- Diploma Plc — 1.04%
- Comfort Systems USA Inc — 0.93%
- Ati Inc — 0.88%
- Global Unichip Corp — 0.76%
- Lumentum Holdings Inc — 0.74%
- Crane Co — 0.72%
- Asmpt Ltd — 0.70%
SPDW top 10
- Samsung Electronics Co Ltd — 2.96%
- SK hynix Inc — 2.79%
- ASML Holding NV — 2.28%
- State Street Global Advisors — 1.85%
- HSBC Holdings PLC — 0.97%
- AstraZeneca PLC — 0.87%
- Roche Holding AG — 0.86%
- Royal Bank of Canada — 0.86%
- Novartis AG — 0.86%
- Nestle SA — 0.80%
FAQ
What is the difference between RSLCX and SPDW?
Which is cheaper, RSLCX or SPDW?
Should I own both RSLCX and SPDW?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.